Cardiovascular drugs: implications for dental practice. Part 2--antihyperlipidemics and antithrombotics.
Appropriate preoperative assessment of the dental patient should always include an analysis of the patient's medications. Cardiovascular diseases are the most common group of medical disorders that dentists encounter, and the number of drugs prescribed for managing these conditions is staggering. This justifiably raises concern and probable confusion regarding side effects and possible drug interactions with medications the dentist may deem necessary for dental care. This continuing education article is the second in a series that will address essential pharmacology of medications commonly prescribed for chronic medical care. A reasonable understanding of these agents will allow the dentist to better appreciate the medical status of their patients, to appreciate the actual risks associated with antithrombotic medications, and to avoid adverse interactions with drugs the dentist might administer or prescribe.
Becker
Daniel E
DE
Sinclair Community College, Miami Valley Hospital, Dayton, OH 45409, USA. dan.becker@sinclair.edu
D000925:Anticoagulants / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D017742:Dental Care for Chronically Ill; D004347:Drug Interactions; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D053210:Pharmaceutical Preparations, Dental / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019106:Postoperative Hemorrhage / Q000517:prevention & control
D000925:Anticoagulants; D000960:Hypolipidemic Agents; D053210:Pharmaceutical Preparations, Dental; D010975:Platelet Aggregation Inhibitors